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Abstract
Background: Reduction in bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA)
occurs in secondary hyperparathyroidism associated with chronic kidney disease. BMD generally increases following
parathyroidectomy, however longitudinal changes to other DXA-derived parameters, the trabecular bone score
(TBS) and hip structural analysis (HSA), have not been described. Postoperative calcium requirements and positive
calcium balance raise concerns for an increased risk of vascular calcification. This case illustrates the dramatic
increase in BMD that can follow parathyroidectomy in a patient on dialysis, and for the first time demonstrates
improvements to HSA parameters and to the TBS.
Case presentation: A 30-year old woman on haemodialysis underwent subtotal parathyroidectomy for secondary
hyperparathyroidism. She developed a post-operative ‘hungry bone syndrome’ requiring substantial calcium and
calcitriol supplementation. Six months post-parathyroidectomy, BMD increased by 42% at the lumbar spine, 30% at
the femoral neck and 25% at the total proximal femur, with increases sustained over the following 18 months. The
TBS increased by 8%. HSA showed a 63% increase in femoral neck cortical thickness and 38% reduction in the
buckling ratio, consistent with increased femoral neck stability. The abdominal aortic vascular calcification score (0–
24) increased from zero 8-years pre-parathyroidectomy to 2/24 at 18-months post-parathyroidectomy.
Conclusion: BMD losses incurred by secondary hyperparathyroidism recover rapidly after parathyroidectomy,
particularly at sites of trabecular bone. Bone architectural parameters, measured as the TBS and by HSA, also
improve. Greater BMD gains may be associated with higher post-operative calcium requirements. While bone is the
major reservoir for post-parathyroidectomy calcium supplementation, positive calcium balance may contribute to
vascular calcification risk.
Keywords: Hyperparathyroidism, Parathyroidectomy, Bone mineral density, Hip structural analysis
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: g.elder@garvan.org.au
1Department of Renal Medicine, Westmead Hospital, Westmead, NSW 2145,
Australia
2University of Notre Dame Medical School, Darlinghurst, NSW, Australia
Full list of author information is available at the end of the article
Lin et al. BMC Nephrology          (2020) 21:513 
https://doi.org/10.1186/s12882-020-02168-y
Background
Many patients with end-stage kidney disease (ESKD)
and secondary hyperparathyroidism have reduced bone
mineral density (BMD), particularly in regions consisting
primarily of cortical bone, and with relative sparing of
trabecular bone. Following parathyroidectomy, BMD
generally increases, but longitudinal changes to the tra-
becular bone score, and to parameters measured by hip
structural analysis have not been described. In addition,
post-operative positive calcium balance caused by re-
quirements for massive supplementation with calcium
and calcitriol or its analogues, raises concern for the risk
of vascular calcification.
Case presentation
A 30-year old woman underwent subtotal parathyroidec-
tomy in September 2018, with removal of three parathy-
roid glands and auto-transplantation of half an excised
gland to the sternocleidomastoid. Her background in-
cluded ESKD secondary to atypical haemolytic uraemic
syndrome, with haemodialysis from 2009 until a living-
related kidney transplant in 2010 at the age of 22. How-
ever, disease recurrence resulted in graft failure, neph-
rectomy and recommencement of home haemodialysis
in 2014.
In 2015, 1 year after recommencing dialysis, her serum
parathyroid hormone (PTH) was 111.3 pmol/L (normal
range 1.6–7.5 pmol/L), rising to 273 pmol/L in 2017.
Hand X-rays showed subperiosteal resorption consistent
with hyperparathyroidism (Fig. 1a). In September 2018
her medications included calcitriol 0.25 μg alternating
with 0.5 μg daily, sevelamer 2400 mg three-times daily
and risedronate 35 mg weekly, which was discontinued
3 weeks prior to her parathyroidectomy in September
2018. Despite pre-operative loading with calcitriol
2.25 μg daily for 3 days, she developed a postoperative
‘hungry bone syndrome’ requiring intermittent intraven-
ous calcium for up to 17 days, and daily doses of 8 μg
calcitriol and 9600 mg calcium carbonate at discharge.
She was also dialysed against an ionised calcium dialys-
ate of 1.7 mmol/L for 6 months. Three months post-
parathyroidectomy her daily dose of calcitriol had re-
duced to 1.5 μg and calcium carbonate 600 mg, which
was maintained until a second kidney transplant in Feb-
ruary 2020. Values of serum calcium, phosphate, ALP,
PTH and bone turnover markers are shown in Table 1.
Her BMD was measured by dual-energy X-ray absorp-
tiometry (DXA) at her first transplant in 2010, 8 months
prior to parathyroidectomy in January 2018, 6 months
after parathyroidectomy in March 2019 and at her 2nd
transplant in March 2020 (Table 2). The trabecular bone
score (TBS) and hip structural analysis (HSA) were also
measured from DXA pre- and post-parathyroidectomy
(Table 2). TBS is an indirect measure of cancellous bone
microarchitectural integrity, and HSA provides informa-
tion on cortical thickness at sites around the hip, and
the buckling ratio (BR), calculated as the femoral neck
radius divided by the femoral neck cortical thickness.
Higher BR values are consistent with increased femoral
neck instability.
By 6 months post-parathyroidectomy, BMD at the
lumbar spine increased by 42% and at the hip by 25–
Fig. 1 a Hand X-ray demonstrating cortical erosion of the radial aspect of the right middle phalanges (X) and loss of distal tuft of the right index
finger (Y). b Rugger-Jersey spine with an alternating sclerotic-lucent appearance is characteristic of hyperparathyroidism. Sclerosis occurs towards
the vertebral endplates, which are a bilayer of porous, fused trabecular bone, which allows for nutrient transport to the intervertebral disc, and
cartilage with horizontally oriented collagen fibres. Linear calcification is visible in the abdominal aorta opposite the L4 vertebra, together with a
fleck opposite L3
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30%. The TBS T-score increased from + 0.8 to 2. Using
HSA, the femoral neck cortical thickness increased by
63% and the buckling ratio fell by 38%. Her BMI
remained stable throughout. The abdominal aorta calci-
fication score (AACS) (0–24) was measured by the
Kauppila semiquantitative scoring method from a lateral
Table 1 Laboratory values before and after parathyroidectomy in September 2018, and kidney transplantation in February 2020.
Patient was on haemodialysis from 2014 to February 2020








Corrected Calcium (2.15–2.55 mmol/L) 2.23 2.29 2.37 2.47 2.32
Phosphate (0.75–1.50 mmol/L) 1.93 1.75 0.92 1.50 0.96
Parathyroid Hormone (1.6–7.5 pmol/L) 273.3 267.9 18.0 2.8 9.8
Alkaline Phosphatase (30–110 U/L) 353 503 41 43 38
CTX (100–700 ng/L) – – – 879 472
P1NP (15–90 μg/L) – – – 127 48
PTx Parathyroidectomy, Tx Kidney transplantation, CTX C-Terminal Collagen Type 1 Telopeptide Crosslinks, P1NP Procollagen Type 1 N-Terminal Propeptide
Table 2 Bone mineral densities (BMD), trabecular bone score (TBS) and hip structural analysis parameters over time. Due to her age,
T and Z-scores are identical







LS BMD (g/cm2) 1.06 1.02 1.44 1.38
LS T-score −0.3 −1.4 + 1.8 + 1.3
% Change Baseline + 42% + 38%
TPF BMD (g/cm2) 0.94 0.84 1.05 1.16
TPF T-score −0.2 −1.6 0 + 0.8
% Change Baseline + 25% + 36%
FN BMD (g/cm2) 0.94 0.81 1.05 1.16
FN T-score 0.0 −1.6 + 0.2 + 1.1
%Change Baseline + 30% + 43%
UD-R BMD (g/cm2) 0.28c 0.27 0.31 0.34
UD-R T-score −0.9c −4.3 −3.4 −2.8
% Change Baseline + 13% + 23%
1/3-R BMD (g/cm2) 0.76c 0.62 0.59 0.63
1/3-R T-score −2.9 −3.3 −2.9
% Change Baseline −4.8% + 1.6%
TBS 1.56 1.68 1.56
TBS T-score + 0.8 + 2.0 + 0.8
% Change Baseline + 8% 0%
Hip Geometry and Hip Structural Analysis
Femoral neck cortical width (mm) (% Change) 4.6 7.5 (+ 63%) 6.9 (+ 50%)
Femoral calcar width (mm) (% Change) 3.5 4.1 (+ 17%) 4.2 (+ 20%)
Femoral shaft width (mm) (% Change) 5.5 5.6 (+ 1.8%) 6.5(+ 18%)
Buckling Ratio (% Change) 3.4 2.1 (−38%) 2.2 (−35%)
Body Mass Index (kg/m2) 26.71 26.80 25.64
aScan performed on Norland XR800
bScan performed on Lunar iDXA
cNorland measures combined ultradistal radius and ulnar BMD. 1/3 radius T-score was unavailable
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spine X-ray that included the abdominal aorta [1]. The
score was zero in 2011 and 2/24 in March 2020 (Fig. 1b).
Radiological changes of Rugger-Jersey spine were
present in 2011 and were more prominent in 2020
(Fig. 1b).
Discussion and conclusions
This patient’s BMD declined between 2010 and January
2018, with the likely nadir immediately pre-
parathyroidectomy. Although moderately elevated circadian
PTH values are anabolic to bone, persistently high values in-
crease osteoblast expression of RANK ligand and reduce
levels of osteoprotegerin, the decoy receptor for RANK lig-
and, which increases osteoclastogenesis and osteoclast activ-
ity. In addition, high PTH levels cause proliferation of pre-
osteoblasts, which do not mature due to a lack of bone mor-
phogenic protein 7, a growth factor primarily of renal origin
[1]. The effects of hyperparathyroidism differ by site [2], with
exclusively cortical sites such as the metacarpals and 1/3 dis-
tal radius often showing greatest BMD loss. However, using
peripheral quantitative computed tomography, deterioration
of trabecular bone has also been demonstrated in dialysis pa-
tients with hyperparathyroidism and patients with primary
hyperparathyroidism [3, 4]. In this patient, predominantly
cortical forearm sites were most severely affected prior to
parathyroidectomy, with the 1/3 radius T-score − 2.9 and
ultradistal radius T-score− 4.3, while the hip and vertebrae
showed lesser BMD reductions.
Within 6 months of parathyroidectomy, BMD gains up
to 42% occurred at the spine and hip, with a smaller but
significant improvement at the ultradistal radius and no
significant change at the 1/3 radius, a site of cortical
bone. After parathyroidectomy, the high surface area of
trabecular bone facilitates mineralisation of former re-
sorption sites, and secondary mineralisation due to re-
duced bone remodelling, whereas in cortical bone, the
reduced cortical thickness and increased porosity are less
readily repaired. In the lumbar spine, the TBS was high
normal (TBS T-score + 0.8) prior to parathyroidectomy,
suggesting that the trabecular network had not been se-
verely compromised in this patient. The TBS showed an
increase following parathyroidectomy, which returned to
the baseline value over the subsequent year on dialysis.
Patients with primary and secondary hyperparathyr-
oidism are recognised to have gains in BMD of 10–15%
following parathyroidectomy [5, 6], and patients on
haemodialysis have recorded gains of 7–23% [7]. The
‘hungry bone syndrome’ has also been associated with
impressive BMD gains. In a case series of Indian patients
with primary hyperparathyroidism, 46 of 51 patients de-
veloped post-operative hypocalcaemia, with BMD in-
creases at 12 months of 106% (IQR 67–178%) at the
spine and 133% (IQR 54–176%) at the hip [8]. The
current case demonstrates that large increases in BMD
may also occur in a patient on dialysis with severe sec-
ondary hyperparathyroidism and the ‘hungry bone
syndrome’.
HSA uses two-dimensional hip DXA images to esti-
mate bone geometry and bone strength. HSA has been
shown to enhance hip fracture risk stratification and is
comparable to CT-based HSA measurements [9, 10]. A
recent study showed that HSA parameters are markedly
abnormal in patients on dialysis [11], but longitudinal
changes to HSA parameters have not been reported.
This patient showed marked improvements in all hip pa-
rameters including femoral neck, calcar and shaft width,
and a reduction in the buckling ratio after parathyroid-
ectomy, indicative of improved femoral neck stability
and possibly lower fracture risk.
The necessity for high dose calcium and vitamin D fol-
lowing parathyroidectomy and treatment of the ‘hungry
bone syndrome’ raises concern for the development of
vascular calcification due to a positive calcium balance
[12]. This patient required ongoing high dose oral cal-
cium and calcitriol and was dialysed against a high di-
alysate calcium for 6 months from the time of
parathyroidectomy. The 2017 Kidney Disease Improving
Global Outcomes (KDIGO) guidelines for Mineral and
Bone Disorders suggest that patients identified with vas-
cular calcification on a lateral abdominal radiograph be
considered at highest cardiovascular risk [13] and recent
data indicates that the AACS (0–24) also predicts car-
diovascular risk and mortality after transplantation [14].
Over the period from 2011 to 2020, this patient’s AACS
(0–24) increased from zero to 2/24. This small, but pos-
sibly significant rise may reflect her longer time on dialy-
sis, increasing age, or hyperparathyroidism and markedly
elevated ALP, which hydrolyses pyrophosphate, an en-
dogenous inhibitor of calcification in blood vessels and
bone. However, we cannot exclude a contribution from
the positive calcium balance that occurred during treat-
ment of her post-parathyroidectomy hypocalcaemia. For
a patient with hypocalcaemia, even relatively low (1.25
mmol/L) calcium dialysate may result in positive calcium
mass transfer from dialysate to blood [13] .
This patient’s clinical progress demonstrates that
BMD losses associated with secondary hyperparathyroid-
ism recover after parathyroidectomy, particularly at sites
of trabecular bone. There may also be improvement in
bone architectural parameters, because TBS and HSA
parameters improved. Longitudinal changes to these pa-
rameters have not been previously reported in patients
on dialysis following parathyroidectomy. BMD gains
may be greater in patients who develop a ‘hungry bone
syndrome’. Although bone is the major reservoir for cal-
cium following parathyroidectomy, we cannot exclude
the possibility of positive calcium balance potentiating
risks for progression of vascular calcification.
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